Matches in Nanopublications for { ?s ?p "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP650932.RAhqBZ_1rdTEYLt4AvR_q5hozPW0Ae8BXY90q0IDnQLjk130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650932.RAhqBZ_1rdTEYLt4AvR_q5hozPW0Ae8BXY90q0IDnQLjk130_provenance.
- NP602460.RAy6qkaY3kB8rOpEeLKGSMmlEG0YXYw_BeNt9AD9b45X4130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP602460.RAy6qkaY3kB8rOpEeLKGSMmlEG0YXYw_BeNt9AD9b45X4130_provenance.
- NP518481.RATLX1Pe-XRGmtMevYm5cUYrK7vFJa8PVJXWr75unBvD8130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518481.RATLX1Pe-XRGmtMevYm5cUYrK7vFJa8PVJXWr75unBvD8130_provenance.
- NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736078.RA25WG82KCCL7_am-ekEsbas-vmAnHMZn574Ov1QxCLFM130_provenance.
- NP593584.RAL15irw7jr9tyNg4b4_8uAYEvnrc1QcznqJtB_RMb5NU130_assertion description "[It was 12% (3/25) in systemic lupus erythematosus, 9.5% (2/21) in primary Sj�gren's syndrome, 10% (1/10) in systemic sclerosis, 20% (2/10) in ankylosing spondylitis, 12.5% (1/8) in viral hepatitis type B, and 0% (0/2) in tuberculosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593584.RAL15irw7jr9tyNg4b4_8uAYEvnrc1QcznqJtB_RMb5NU130_provenance.